A drawing of a doctor talking to a patient about clinical trials on a backdrop that is all yellow ovals on one side, and all different coloured shapes on the otherside.
Case Study

Supporting greater diversity in clinical trial recruitment.

Inflection Point

A biotech was launching phase 3 clinical trials in a therapeutic area with a high prevalence among Black Americans. In earlier phases, clinical trial participants had not been representative of the patient population. Our client saw an opportunity to create recruitment material that would support diversity in trial recruitment, and ultimately produce more representative clinical trial data.


How We Helped

We collaborated with the Head of  Diversity, Equity, and Inclusion (DEI) for clinical trials, to align on a tangible starting point and quickly demonstrate meaningful change.

With extensive experience working with clinical trial participants, our team came to the table with an in-depth understanding of common fears and misunderstandings. That allowed us to quickly deliver materials with representative, patient-friendly language, and curate content to focus on trial participants’ most pressing concerns.

We collaborated with the client’s broader team to create organizational alignment around the materials — from the visual representation of diverse populations to the language used. For the internal team, it was an energizing example of making DEI more concrete and tangible in the organization.


Outcomes

We delivered recruitment materials that were easy-to-understand and culturally relevant, especially to populations most likely to benefit from their treatments. Meanwhile, the deliverables helped our client demonstrate the impact of practical, on-the-ground initiatives and generated momentum for our client’s team. Our recruitment materials were was an important stepping stone for the organization’s larger goal of realizing DEI in clinical trials. The finished materials were distributed to our client’s clinical trial sites and translated into three languages.